Synthes (USA) Products LLC recalled 122 surgical screws on September 26, 2025. Mislabeling of screw lengths poses a serious risk to patients. Affected products include those used in the RFN-ADVANCED and Tibial Nail Advanced Systems.
Although the etched length on the screw is correct, the length marked on the external packaging is incorrect. Specifically, 42mm screws were packaged and labeled as 46mm, while 46mm screws were packaged and labeled as 42mm.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Synthes (USA) Products LLC or your healthcare provider for instructions. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The recall involves LOW PROF LCKNG SCREW, F/IM NAIL 5.0MM / L, 42MM / XL25/ STER, Product Code: 04.045.342TS. The screws were distributed worldwide, including in the United States and Canada.
The screws are mislabeled, with 42mm screws packaged as 46mm and vice versa. This mislabeling can lead to incorrect surgical procedures.
No injuries or incidents have been reported to date. However, the potential for serious complications exists due to the incorrect labeling.
Stop using the screws immediately. Follow the recall instructions from Synthes or consult your healthcare provider.
For further instructions, contact Synthes (USA) Products LLC. Visit the FDA website for more details.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.